From: Stakeholder involvement in systematic reviews: a scoping review
 | Total | Patients/carers included | No patients/carers included | Unclear | ||||
---|---|---|---|---|---|---|---|---|
USA | 92 | 31.6% | 18 | 19.6% | 42 | 45.7% | 32 | 34.8% |
UK | 76 | 26.1% | 42 | 55.3% | 16 | 21.1% | 18 | 23.7% |
Canada | 29 | 10.0% | 3 | 10.3% | 17 | 58.6% | 9 | 31.0% |
Australia | 22 | 7.6% | 5 | 22.7% | 7 | 31.8% | 10 | 45.5% |
Netherlands | 14 | 4.8% | 8 | 57.1% | 4 | 28.6% | 2 | 14.3% |
Germany | 12 | 4.1% | 2 | 16.7% | 8 | 66.7% | 2 | 16.7% |
Italy | 7 | 2.4% | 1 | 14.3% | 4 | 57.1% | 2 | 28.6% |
France | 6 | 2.1% | 1 | 16.7% | 3 | 50.0% | 2 | 33.3% |
Spain | 5 | 1.7% | 3 | 60.0% | 1 | 20.0% | 1 | 20.0% |
Other (countries with < 5 papers*) | 28 | 9.6% | 5 | 17.9% | 17 | 60.7% | 6 | 21.4% |